Post-approval studies (Phase 4)Study completedNCT00272311
What this trial is testing
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
Who this might be right for
Cardiovascular DiseasesMetabolic Syndrome XAtherosclerosis
Florida Atlantic University 70